171 related articles for article (PubMed ID: 14870836)
1. [Endocrine therapy of causation: role of aromatase inhibitors in breast cancer].
Longo F; Mansueto G
Tumori; 2003; 89(6):21-8. PubMed ID: 14870836
[No Abstract] [Full Text] [Related]
2. Anti-tumor effects of letrozole.
Miller WR; Anderson TJ; Dixon JM
Cancer Invest; 2002; 20 Suppl 2():15-21. PubMed ID: 12442345
[TBL] [Abstract][Full Text] [Related]
3. Critics question price of success in halted clinical trial of aromatase inhibitor letrozole.
Twombly R
J Natl Cancer Inst; 2003 Dec; 95(23):1738-9. PubMed ID: 14652229
[No Abstract] [Full Text] [Related]
4. Letrozole in breast cancer.
Shahab N
N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971058
[No Abstract] [Full Text] [Related]
5. [The ATAC study on adjuvants in breast cancer].
Bravi S
Suppl Tumori; 2004; 3(4):S15. PubMed ID: 15206200
[No Abstract] [Full Text] [Related]
6. Combination hormonal therapy involving aromatase inhibitors in the management of women with breast cancer.
Ingle JN; Suman VJ; Jordan VC; Dowsett M
Endocr Relat Cancer; 1999 Jun; 6(2):265-9. PubMed ID: 10731119
[TBL] [Abstract][Full Text] [Related]
7. [Superiority of letrozole compared with tamoxifen as first line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group].
Illiger HJ
Strahlenther Onkol; 2002 Feb; 178(2):111-3. PubMed ID: 11942036
[No Abstract] [Full Text] [Related]
8. [The ATAC study on adjuvants in breast cancer. What kind of repercussions will it have on clinical practice?].
Gamucci T
Suppl Tumori; 2004; 3(4):S16. PubMed ID: 15206201
[No Abstract] [Full Text] [Related]
9. [National Conference of Medical Oncology. Controversies in the treatment of breast cancer. Genova, October 28, 2000].
Longo F
Tumori; 2000; 86(6):A13-8. PubMed ID: 11271674
[No Abstract] [Full Text] [Related]
10. Letrozole after tamoxifen for breast cancer--what is the price of success?
Bryant J; Wolmark N
N Engl J Med; 2003 Nov; 349(19):1855-7. PubMed ID: 14551339
[No Abstract] [Full Text] [Related]
11. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
Goss PE; Ingle JN; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Tu D; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Therasse P; Palmer MJ; Pater JL
N Engl J Med; 2003 Nov; 349(19):1793-802. PubMed ID: 14551341
[TBL] [Abstract][Full Text] [Related]
12. Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?
Wu K; Brown P
J Natl Cancer Inst; 2003 Jun; 95(11):766-7. PubMed ID: 12783921
[No Abstract] [Full Text] [Related]
13. [Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer: the MA-17 study].
Gori S; Anastasi P; Marrocolo F
Suppl Tumori; 2004; 3(4):S27-31. PubMed ID: 15206206
[No Abstract] [Full Text] [Related]
14. [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Hormone therapy: what kind of evidence?].
Angiolini C
Suppl Tumori; 2004; 3(4):S75-6. PubMed ID: 15206219
[No Abstract] [Full Text] [Related]
15. Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
Roseman BJ; Buzdar AU; Singletary SE
J Surg Oncol; 1997 Nov; 66(3):215-20. PubMed ID: 9369969
[TBL] [Abstract][Full Text] [Related]
16. [Extended adjuvant hormone therapy (in breast cancer): Why? To whom? What? How long?].
Kahán Z
Magy Onkol; 2008 Jun; 52(2):225-6. PubMed ID: 18640899
[No Abstract] [Full Text] [Related]
17. Hormonal therapy in early and advanced breast cancer.
Buzdar AU
Breast J; 2004; 10 Suppl 1():S19-21. PubMed ID: 14984485
[TBL] [Abstract][Full Text] [Related]
18. Beyond tamoxifen--extending endocrine treatment for early-stage breast cancer.
Burstein HJ
N Engl J Med; 2003 Nov; 349(19):1857-9. PubMed ID: 14551340
[No Abstract] [Full Text] [Related]
19. [Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer. The example of the MA-17 study].
Forciniti S
Suppl Tumori; 2004; 3(4):S25-6. PubMed ID: 15206205
[No Abstract] [Full Text] [Related]
20. Should aromatase inhibitors replace tamoxifen?
Drug Ther Bull; 2003 Aug; 41(8):57-9. PubMed ID: 12966738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
